Market Cap 14.48B
Revenue (ttm) 221.90M
Net Income (ttm) -535.76M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -241.44%
Debt to Equity Ratio -0.96
Volume 1,597,200
Avg Vol 2,304,268
Day's Range N/A - N/A
Shares Out 192.71M
Stochastic %K 98%
Beta 1.26
Analysts Strong Sell
Price Target $85.53

Company Profile

BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers. The company offers Attruby, a next-generation oral small molecule near-complete TTR stabilizer for the treatment of cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM); low-dose infigratinib, an oral FGFR1-3 selective tyrosine kinase inhibitor, which is in Phase 3 doub...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 391 9740
Address:
3160 Porter Drive, Suite 250, Palo Alto, United States
BIOTECH_GURU
BIOTECH_GURU Dec. 13 at 3:36 PM
$BBIO $ALNY $PFE $BMRN $ASND $BBIO keeps getting upgrades left and right. Triple digits are in sight! 🔥🔥🔥🚀🚀🚀
0 · Reply
WAJeff
WAJeff Dec. 13 at 5:32 AM
$BBIO $75.24 ath
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 11 at 11:29 PM
Actionable Trade Alert for $BBIO: Current market context shows $BBIO closing at $73.45 with an RSI of 74.49, indicating an overbought condition. The stock is above its 30-day moving average (MA30) of 67.92 and 50-day moving average (MA50) of 63.28, suggesting bullish momentum. However, the high of $75.1 within the last 60 days indicates potential resistance. Directional bias remains bullish, but caution is warranted due to the high RSI. Suggested entry at $73.50, with a stop loss set at $71.00 (risking $2.50). Take profit targets: 1. $76.00 (4.1% ROI) 2. $78.00 (6.9% ROI) 3. $86.00 (17% ROI) This trade plan allows for a favorable risk-reward ratio while capitalizing on potential upward movement. Monitor closely for any signs of reversal as we approach resistance levels. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
G101SPM
G101SPM Dec. 11 at 1:11 PM
$BBIO O$73.99 bid. DAC (dollar average cost) (4) $24.53. CHANGE EXIT TO $95.00 FROM $80.00 https://stocktwits.com/search/u/G101SPM?symbol=BBIO BRIEF: BridgeBio (BBIO) initiated with an Outperform at Bernstein, tgt $94
0 · Reply
Quantumup
Quantumup Dec. 11 at 11:17 AM
Bernstein🏁 $BBIO at an Outperform-$94 and said, 'Ample Upside Even if Attruby Hits Choppy Seas. Initiate at Outperform, $94 PT' $ALNY $PFE AZN BAYRY $BMRN $ASND Here's what Bernstein additionally said in its BridgeBio initiation report: https://x.com/Quantumup1/status/1999075008165924906?s=20
0 · Reply
JarvisFlow
JarvisFlow Dec. 11 at 10:55 AM
Bernstein has updated their rating for BridgeBio Pharma ( $BBIO ) to Outperform with a price target of 94.
0 · Reply
OptionRunners
OptionRunners Dec. 10 at 8:09 PM
$BBIO buyer of the January 16th 2026 $80 calls 1,232 times for $2.25
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 3:33 AM
Actionable Trade Alert for $BBIO: Market Context: $BBIO is currently trading at $71.67, nearing its 60-day high of $75.1. The RSI at 67.65 indicates a strong bullish momentum but is approaching overbought territory. The stock is above its 30-day MA of 67.42 and significantly above its 50-day MA of 62.46, suggesting a bullish trend. Directional Bias: The upward movement is supported by the proximity to the 60-day high and the bullish alignment of MAs, indicating potential for further gains. However, caution is warranted due to the high RSI. Trade Plan: - Suggested Entry: $72.00 - Stop Loss: $68.00 (4% below entry) - Take Profit Targets: 1. $75.00 (4.17% ROI) 2. $78.00 (8.33% ROI) 3. $84.00 (16.67% ROI) With a focus on the potential for a 17% ROI or more at target 3, this trade aligns with current market conditions and technical indicators. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
SimpleWinningSetups
SimpleWinningSetups Dec. 9 at 9:33 PM
Hedge Alert Live - Protect Your Portfolio Contract: $BBIO $70.00 Put · DEC 19, 2025 Exp Entry Price: $1.40 - $1.55 Exit Price Target: $2.81 Profit Margin: +101% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 8 at 11:21 PM
Actionable Trade Alert for $BBIO: Market Context: $BBIO is currently trading at $74.74, near its 60D high of $75.1, suggesting bullish momentum. The RSI at 73.81 indicates overbought conditions, which may lead to a pullback. However, the strong upward trend is supported by the MA30 at $67.16 and MA50 at $62.08, indicating solid bullish sentiment. Directional Bias: The price is above both MA30 and MA50, reinforcing a bullish outlook despite the high RSI. The proximity to the 60D high suggests a potential breakout or reversal. Trade Plan: - Suggested Entry: $74.00 (considering a slight pullback) - Stop Loss: $71.00 (below recent support) - Take Profit Targets: - TP1: $77.00 (4.5% gain) - TP2: $80.00 (7.5% gain) - TP3: $87.00 (16.4% gain) This trade plan offers a potential ROI of over 17% on TP3 while managing risk effectively. Monitor for price action around the entry level. https://privateprofiteers.com
0 · Reply
Latest News on BBIO
BridgeBio to Participate in December Investor Conferences

Nov 25, 2025, 7:30 AM EST - 18 days ago

BridgeBio to Participate in December Investor Conferences


BridgeBio to Participate in November Investor Conferences

Nov 4, 2025, 7:30 AM EST - 5 weeks ago

BridgeBio to Participate in November Investor Conferences


BridgeBio Pharma, Inc. (BBIO) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 10:56 PM EDT - 6 weeks ago

BridgeBio Pharma, Inc. (BBIO) Q3 2025 Earnings Call Transcript


BridgeBio to Participate in September Investor Conferences

Aug 27, 2025, 7:30 AM EDT - 3 months ago

BridgeBio to Participate in September Investor Conferences


BridgeBio Pharma, Inc. (BBIO) Q2 2025 Earnings Call Transcript

Aug 9, 2025, 4:30 AM EDT - 4 months ago

BridgeBio Pharma, Inc. (BBIO) Q2 2025 Earnings Call Transcript


BridgeBio: New Data Bolsters The Bull Case

Jun 4, 2025, 3:34 AM EDT - 6 months ago

BridgeBio: New Data Bolsters The Bull Case


BridgeBio Pharma, Inc. (BBIO) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 9:43 PM EDT - 8 months ago

BridgeBio Pharma, Inc. (BBIO) Q1 2025 Earnings Call Transcript


BridgeBio: Early Signs Point To Blockbuster Revenues

Apr 22, 2025, 11:14 AM EDT - 8 months ago

BridgeBio: Early Signs Point To Blockbuster Revenues


BIOTECH_GURU
BIOTECH_GURU Dec. 13 at 3:36 PM
$BBIO $ALNY $PFE $BMRN $ASND $BBIO keeps getting upgrades left and right. Triple digits are in sight! 🔥🔥🔥🚀🚀🚀
0 · Reply
WAJeff
WAJeff Dec. 13 at 5:32 AM
$BBIO $75.24 ath
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 11 at 11:29 PM
Actionable Trade Alert for $BBIO: Current market context shows $BBIO closing at $73.45 with an RSI of 74.49, indicating an overbought condition. The stock is above its 30-day moving average (MA30) of 67.92 and 50-day moving average (MA50) of 63.28, suggesting bullish momentum. However, the high of $75.1 within the last 60 days indicates potential resistance. Directional bias remains bullish, but caution is warranted due to the high RSI. Suggested entry at $73.50, with a stop loss set at $71.00 (risking $2.50). Take profit targets: 1. $76.00 (4.1% ROI) 2. $78.00 (6.9% ROI) 3. $86.00 (17% ROI) This trade plan allows for a favorable risk-reward ratio while capitalizing on potential upward movement. Monitor closely for any signs of reversal as we approach resistance levels. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
G101SPM
G101SPM Dec. 11 at 1:11 PM
$BBIO O$73.99 bid. DAC (dollar average cost) (4) $24.53. CHANGE EXIT TO $95.00 FROM $80.00 https://stocktwits.com/search/u/G101SPM?symbol=BBIO BRIEF: BridgeBio (BBIO) initiated with an Outperform at Bernstein, tgt $94
0 · Reply
Quantumup
Quantumup Dec. 11 at 11:17 AM
Bernstein🏁 $BBIO at an Outperform-$94 and said, 'Ample Upside Even if Attruby Hits Choppy Seas. Initiate at Outperform, $94 PT' $ALNY $PFE AZN BAYRY $BMRN $ASND Here's what Bernstein additionally said in its BridgeBio initiation report: https://x.com/Quantumup1/status/1999075008165924906?s=20
0 · Reply
JarvisFlow
JarvisFlow Dec. 11 at 10:55 AM
Bernstein has updated their rating for BridgeBio Pharma ( $BBIO ) to Outperform with a price target of 94.
0 · Reply
OptionRunners
OptionRunners Dec. 10 at 8:09 PM
$BBIO buyer of the January 16th 2026 $80 calls 1,232 times for $2.25
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 3:33 AM
Actionable Trade Alert for $BBIO: Market Context: $BBIO is currently trading at $71.67, nearing its 60-day high of $75.1. The RSI at 67.65 indicates a strong bullish momentum but is approaching overbought territory. The stock is above its 30-day MA of 67.42 and significantly above its 50-day MA of 62.46, suggesting a bullish trend. Directional Bias: The upward movement is supported by the proximity to the 60-day high and the bullish alignment of MAs, indicating potential for further gains. However, caution is warranted due to the high RSI. Trade Plan: - Suggested Entry: $72.00 - Stop Loss: $68.00 (4% below entry) - Take Profit Targets: 1. $75.00 (4.17% ROI) 2. $78.00 (8.33% ROI) 3. $84.00 (16.67% ROI) With a focus on the potential for a 17% ROI or more at target 3, this trade aligns with current market conditions and technical indicators. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
SimpleWinningSetups
SimpleWinningSetups Dec. 9 at 9:33 PM
Hedge Alert Live - Protect Your Portfolio Contract: $BBIO $70.00 Put · DEC 19, 2025 Exp Entry Price: $1.40 - $1.55 Exit Price Target: $2.81 Profit Margin: +101% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 8 at 11:21 PM
Actionable Trade Alert for $BBIO: Market Context: $BBIO is currently trading at $74.74, near its 60D high of $75.1, suggesting bullish momentum. The RSI at 73.81 indicates overbought conditions, which may lead to a pullback. However, the strong upward trend is supported by the MA30 at $67.16 and MA50 at $62.08, indicating solid bullish sentiment. Directional Bias: The price is above both MA30 and MA50, reinforcing a bullish outlook despite the high RSI. The proximity to the 60D high suggests a potential breakout or reversal. Trade Plan: - Suggested Entry: $74.00 (considering a slight pullback) - Stop Loss: $71.00 (below recent support) - Take Profit Targets: - TP1: $77.00 (4.5% gain) - TP2: $80.00 (7.5% gain) - TP3: $87.00 (16.4% gain) This trade plan offers a potential ROI of over 17% on TP3 while managing risk effectively. Monitor for price action around the entry level. https://privateprofiteers.com
0 · Reply
BIOTECH_GURU
BIOTECH_GURU Dec. 6 at 11:52 AM
$BBIO $BBOT my exposure has been via BBIO. Not a bad idea to start building a position soon.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 2:21 AM
Actionable Trade Alert for $BBIO: Market Context: $BBIO is currently trading at $74.76, near its 60-day high of $75.04, indicating bullish momentum. The RSI at 80.16 suggests overbought conditions, which may lead to a pullback or consolidation. However, the strong upward trend is supported by the moving averages, with the MA30 at $65.82 and MA50 at $61.09, both indicating a solid bullish bias. Directional Bias: Given the RSI and proximity to the 60D high, we anticipate a short-term pullback followed by a continuation of the upward trend. Trade Plan: - Suggested Entry: $74.50 - Stop Loss: $71.50 (3% below entry) - Take Profit Targets: 1. Target 1: $78.00 (4% ROI) 2. Target 2: $80.00 (7% ROI) 3. Target 3: $87.50 (17% ROI) This plan allows for a favorable risk-reward ratio while capitalizing on the current bullish trend. Monitor price action closely for any signs of reversal. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 9:55 PM
Actionable Trade Alert for $BBIO: Market Context: $BBIO is currently trading at $74.76, near its 60-day high of $75.04, indicating bullish momentum. The RSI at 80.16 suggests overbought conditions, which may lead to a pullback or consolidation. However, the strong upward trend is supported by the moving averages, with the MA30 at $65.82 and MA50 at $61.09, both indicating a solid bullish bias. Directional Bias: Given the RSI and proximity to the 60D high, we anticipate a short-term pullback followed by a continuation of the upward trend. Trade Plan: - Suggested Entry: $74.50 - Stop Loss: $71.50 (3% below entry) - Take Profit Targets: 1. Target 1: $78.00 (4% ROI) 2. Target 2: $80.00 (7% ROI) 3. Target 3: $87.50 (17% ROI) This plan allows for a favorable risk-reward ratio while capitalizing on the current bullish trend. Monitor price action closely for any signs of reversal. https://privateprofiteers.com
0 · Reply
Quantumup
Quantumup Dec. 5 at 1:17 PM
Morgan Stanley🏁 $BBOT Overweight/$20 $BBIO $RVMD Here's what Morgan Stanley had to say: https://x.com/Quantumup1/status/1996931177412804795?s=20
0 · Reply
BIOTECH_GURU
BIOTECH_GURU Dec. 5 at 2:33 AM
$BBIO this is going to have a 12-15% day rip soon. Still way underpriced. 💥💥💥🚀🚀🚀
1 · Reply
LMXPERTEN
LMXPERTEN Dec. 4 at 7:14 PM
$BBIO 🚂
0 · Reply
knobs101
knobs101 Dec. 4 at 3:58 PM
$BBIO Higher highs and higher lows. Mi gusta.
0 · Reply
WAJeff
WAJeff Dec. 4 at 3:50 PM
$BBIO 75.04 ath
0 · Reply
StockBraker
StockBraker Dec. 4 at 3:44 PM
$BBIO New 52 week high. Personally looking for $85+ to start trimming holdings.
0 · Reply
Quantumup
Quantumup Dec. 4 at 1:26 PM
Goldman Sachs🏁 $TYRA at an Early-Stage Biotech rating. $BBIO $JNJ $INCY $OTSKY Here's what Goldman Sachs had to say in its initiation report: https://x.com/Quantumup1/status/1996570205779099845?s=20
0 · Reply
SimpleWinningSetups
SimpleWinningSetups Dec. 4 at 6:59 AM
Hedge Alert Live - Protect Your Portfolio Contract: $BBIO $72.50 Put · DEC 19, 2025 Exp Entry Price: $3.00 - $3.90 Exit Price Target: $6.48 Profit Margin: +116% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
justiceforb_85
justiceforb_85 Dec. 4 at 2:44 AM
$BBIO continues to impress. Bright future with pending FDA approvals for rare diseases without approved therapies.
0 · Reply